Apotea AB (publ) (FRA:V30) Valuation Rank


FRA:V30 Apotea AB (publ) FRA:V30
19 GF Score
Price €6.84
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Apotea AB (publ) Valuation Rank Related Terms

FRA:V30
19GF Score
Apotea AB (publ) FRA:V30
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apotea AB (publ) Business Description

Other Exchanges APOTEA:SwedenV30:Germany
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
19GF Score

Get the complete analysis for FRA:V30

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.84
Price